Brexpiprazole: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Brexpiprazole. Educational only — not medical advice.
Labeled uses
REXULTI is indicated for: Adjunctive treatment to antidepressants for major depressive disorder (MDD) in adults Treatment of schizophrenia in adults and pediatric patients ages 13 years and older Treatment of agitation associated with dementia due to Alzheimer's disease Limitations of Use: REXULTI is not indicated as an as needed ("prn") treatment for agitation associated with dementia due to Alzheimer's disease [see Clinical Studies (14.3) ] .
Source: FDA labeling via NIH DailyMed (set df891816…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.